Healthcare provider profile · identity verified

Anna G Patton, MD

Family Practice · CATLETTSBURG, KY · NPI 1386684959

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	321	87
Gabapentin	Gabapentin	292	75
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	229	51
Potassium Chloride	Potassium Chloride	217	87
Furosemide	Furosemide	212	93
Pantoprazole Sodium	Pantoprazole Sodium	207	81
Levothyroxine Sodium	Levothyroxine Sodium	186	74
Omeprazole	Omeprazole	184	67
Lisinopril	Lisinopril	181	71
Atorvastatin Calcium	Atorvastatin Calcium	170	75
Amlodipine Besylate	Amlodipine Besylate	154	60
Diazepam	Diazepam	138	40
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	136	58
Clonazepam	Clonazepam	134	28
Losartan Potassium	Losartan Potassium	134	55
Prednisone	Prednisone	133	81
Metformin Hcl	Metformin Hcl	117	48
Albuterol Sulfate Hfa	Albuterol Sulfate	115	48
Metoprolol Tartrate	Metoprolol Tartrate	113	46
Alprazolam	Alprazolam	112	24
Trazodone Hcl	Trazodone Hcl	112	41
Montelukast Sodium	Montelukast Sodium	108	44
Tizanidine Hcl	Tizanidine Hcl	106	40
Ozempic	Semaglutide	99	30
Lorazepam	Lorazepam	97	20
Rosuvastatin Calcium	Rosuvastatin Calcium	96	39
Tramadol Hcl	Tramadol Hcl	95	25
Metoprolol Succinate	Metoprolol Succinate	94	37
Ondansetron Odt	Ondansetron	94	40
Duloxetine Hcl	Duloxetine Hcl	92	31
Famotidine	Famotidine	92	41
Promethazine Hcl	Promethazine Hcl	88	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	87	36
Sertraline Hcl	Sertraline Hcl	86	31
Simvastatin	Simvastatin	80	26
Januvia	Sitagliptin Phosphate	77	19
Pregabalin	Pregabalin	77	18
Citalopram Hbr	Citalopram Hydrobromide	70	30
Hydrochlorothiazide	Hydrochlorothiazide	68	24
Mirtazapine	Mirtazapine	67	25
Fluticasone Propionate	Fluticasone Propionate	66	26
Carvedilol	Carvedilol	64	24
Esomeprazole Magnesium	Esomeprazole Magnesium	64	21
Meloxicam	Meloxicam	64	21
Eliquis	Apixaban	63	18
Ropinirole Hcl	Ropinirole Hcl	60	25
Ibuprofen	Ibuprofen	57	33
Buspirone Hcl	Buspirone Hcl	56	21
Mounjaro	Tirzepatide	55	11
Warfarin Sodium	Warfarin Sodium	55	18
Amitriptyline Hcl	Amitriptyline Hcl	53	21
Diclofenac Sodium	Diclofenac Sodium	53	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	23
Escitalopram Oxalate	Escitalopram Oxalate	52	19
Ventolin Hfa	Albuterol Sulfate	50	25
Tamsulosin Hcl	Tamsulosin Hcl	49	21
Pravastatin Sodium	Pravastatin Sodium	47	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	45	35
Azithromycin	Azithromycin	45	27
Ondansetron Hcl	Ondansetron Hcl	44	13
Zolpidem Tartrate	Zolpidem Tartrate	44	17
Celecoxib	Celecoxib	43	11
Triamcinolone Acetonide	Triamcinolone Acetonide	43	21
Fluconazole	Fluconazole	42	15
Sucralfate	Sucralfate	42	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	13
Atenolol	Atenolol	36	14
Bupropion Xl	Bupropion Hcl	36	13
Oxycodone Hcl	Oxycodone Hcl	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	11
Meclizine Hcl	Meclizine Hcl	32	14
Amoxicillin	Amoxicillin	31	22
Clonidine Hcl	Clonidine Hcl	30	12
Doxycycline Hyclate	Doxycycline Hyclate	30	19
Glipizide	Glipizide	30	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	30	14
Clopidogrel	Clopidogrel Bisulfate	29	15
Fluoxetine Hcl	Fluoxetine Hcl	29	11
Metformin Hcl Er	Metformin Hcl	29	13
Nitroglycerin	Nitroglycerin	28	suppressed
Nystatin	Nystatin	28	15
Synthroid	Levothyroxine Sodium	27	suppressed
Methocarbamol	Methocarbamol	26	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	22
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Spironolactone	Spironolactone	24	13
Topiramate	Topiramate	24	suppressed
Glipizide Er	Glipizide	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Estradiol	Estradiol	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Xarelto	Rivaroxaban	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Allopurinol	Allopurinol	16	suppressed
Flecainide Acetate	Flecainide Acetate	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Levemir Flexpen	Insulin Detemir	15	suppressed
Linzess	Linaclotide	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	11
Clindamycin Hcl	Clindamycin Hcl	14	12
Enalapril Maleate	Enalapril Maleate	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Xifaxan	Rifaximin	14	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Temazepam	Temazepam	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Baclofen	Baclofen	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error